Amber List

TLSITriSalus Life Sciences, Inc.

Healthcare · Medical Devices · small-cap ($333M)
-34.2%
from rolling 252-day high of $7.95 set 2025-12-22 · 241d ago
Current
$5.23
Decline depth
-34.2%
Decline σ
2.6σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$TLSI has been tracked since 2026-03-01. It was down 37.0% from its 52-week high then — now down -34.2%.

It has clawed back 3.3 percentage points off that level. It bottomed 68.3% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

TLSI qualifies for the Amber List on decline depth.

Decline depth
-34.2%
From rolling 252-day high of $7.95, 241d ago. Past the 30% Amber threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
2.6σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (4.42% per day).

The structural read

What price action says about TLSI.

TLSI qualifies for the Amber List on decline depth — down -34.2% from its rolling 252-day high.

Cross-confirmation: also showing 3/5 bearish time frames.

Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (gray), monthly 2U (green).

Earnings on file: 2026-08-06. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about TLSI

What people ask.

Why is TLSI on Broken Stocks?

TLSI qualifies for the Amber List on decline depth. It is down -34.2% from its rolling 252-day high of $7.95, set on 2025-12-22 — 241d ago.

Is TLSI a falling knife?

Not by the strict technical definition. TLSI is down -34.2% from its 52-week high, but that high was set 241d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. TLSI is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is TLSI a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is TLSI trading inside its 52-week range?

At $5.23, TLSI sits 52.7% of the way from its 52-week low ($2.20) to its 52-week high ($7.95). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has TLSI been declining?

The current 34.2% decline accrued over 241d, which annualizes to roughly -51.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does TLSI compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 34 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — TLSI's decline is shallower than the sector median.

Does TLSI's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-08-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.